Organic growth excludes the impact of exchange rate fluctuations, acquisitions and disposals. The impact of exchange rate fluctuations is calculated by converting sales for the current financial year ...
the 4(th) quarter of 2024. EBITDA(1) reached NOK 398 million (NOK 327 million). The result in BioSolutions increased compared with the 4(th) quarter of 2023. BioMaterials remained at the same level, ...
improved by 31%. Costs were stable, and included higher investment in growth, technology and risk management. Operating profit increased by 4%, to EUR 1.5bn. Return on equity 14.3% - earnings per ...
at 7:00 a.m. CET. The quarterly report and the presentation material will be available at this time at: https://investors.orkla.com. The presentation and subsequent Q&A session will be held in English ...
issuance of 14,250,000 new shares at a price of NOK 20 per share, in connection with the successful private placement (the "Private Placement") of new shares in ...
employs around 2300 staff and posted annual gross revenue of USD 1194 million in 2023. Read more on Odfjell.com (https://www.odfjell.com/). This information is ...